US Patent 12083224 Lipid particles for nucleic acid delivery
Patent 12083224 was granted and assigned to Arcturus Therapeutics on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+463 characters)
US Patent 12083224 Lipid particles for nucleic acid delivery
Article
Patent abstract
Nucleic acid immunization is achieved by delivering a nucleic acid (NA), e.g., a mRNA or a DNA, encapsulated within a lipid-NA nanoparticle. The NA encodes an immunogenic compound of interest. The lipid-NA nanoparticle is effective for in vivo delivery of NA to a vertebrate cell, including upon administration to a subject. The lipid-NA nanoparticle are incorporated in pharmaceutical compositions for immunizing subjects against various diseases.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christine Esau0
Jerel Vega0
Padmanabh Chivukula0
Priya Karmali0
Rajesh Mukthavaram0
Samantha Murphy0
Yanjie Bao0
Date of Patent
September 10, 2024
0Patent Application Number
170428480
Date Filed
April 1, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12083224 Lipid particles for nucleic acid delivery
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
